Division of Rheumatology and Immunology

Deanna Edwards, PhD, left, Jin Chen, MD, PhD, and colleagues are studying a new therapeutic strategy for triple-negative breast cancer.
April 1, 2021

Breast cancer cells ‘steal’ nutrients from immune cells: study

Triple-negative breast cancer cells engage in a “glutamine steal” — outcompeting T cells for the nutrient glutamine and impairing their ability to kill tumor cells, Vanderbilt researchers have discovered.

By Leigh MacMillan
Vanderbilt Health Hendersonville is located on Anderson Lane North in the Indian Lake Community.
March 30, 2021

New Vanderbilt Health Hendersonville expands services in Sumner County

Vanderbilt University Medical Center has opened Vanderbilt Health Hendersonville, a new 31,000-square-foot facility that offers adult outpatient specialty care, along with pediatric specialty care and imaging services to the citizens of Sumner and surrounding counties.

By Jill Clendening
January 11, 2021

Microbial RNA and rheumatoid arthritis

Small RNAs — short stretches of genetic material — from microbes may be playing a role in rheumatoid arthritis and other autoimmune diseases.

By Leigh MacMillan
November 12, 2020

New therapeutic target for lung cancer

Vanderbilt researchers have identified a new molecular partner — and potential therapeutic target — in a signaling axis that drives lung cancer.

By Sarah E. Glass
August 20, 2020

A “torque” for tumor blood vessels

Vanderbilt scientists have discovered a new target for normalizing tumor blood vessels to improve cancer immunotherapies.

By Bill Snyder
October 30, 2019

Rheumatology’s Fuchs remembered for dedication to medicine, family

Howard Fuchs, MD, professor of Medicine, Division of Rheumatology and Immunology, died unexpectedly Oct. 28. He was 64.

By VUMC News and Communications
November 8, 2018

New clinic focused on caring for vasculitis patients

Vanderbilt University Medical Center recently debuted a new clinic dedicated to providing a multidisciplinary approach to caring for patients coping with the complex host of chronic disorders known as vasculitis.
By Doug Campbell
February 15, 2018

Team finds stem cell transplant improves scleroderma survival

A new clinical trial by investigators at Vanderbilt University Medical Center (VUMC) and other leading medical centers found that an intensive transplant treatment using the patient’s own stem cells can improve survival and quality of life for patients with advanced scleroderma.
By VUMC News and Communications
November 1, 2017

Bioactive lipids and rheumatoid arthritis

An enzyme that produces bioactive fatty acids has elevated activity in patients with rheumatoid arthritis, supporting further studies to understand its biologic roles in the disease.
By Leigh MacMillan
April 6, 2017

Brumbelow’s calm nature helps keep busy clinic rolling

Taylor Brumbelow has a gift for quickly putting people at ease.
By Doug Campbell
April 14, 2016

Switching breast cancer off

Signaling by a receptor that is overexpressed in aggressive forms of breast cancer has been linked to glutamine metabolism, suggesting new anti-cancer therapeutic targets.
By Marilyn Holt
February 10, 2016

Overcoming lung cancer drug resistance

Vanderbilt investigators have discovered a way to overcome the resistance of some lung cancers to certain targeted therapies, which could lead to more effective treatments for lung cancer patients.
By Marilyn Holt
April 10, 2014

Study tracks new lung cancer drug target

Researchers at Vanderbilt University have identified a potential new drug target in subtypes of lung cancer that are difficult to treat.
By Bill Snyder
1 2 3